Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in combination with standard-of-care Bacillus Calmette-Guerin, or BCG, as induction therapy with or without maintenance in ...

For most investors, generating consistent income alongside capital appreciation is a common goal. For those seeking a blend ...

A Canadian teen's breasts grew fourfold after receiving the Pfizer COVID-19 vaccine, raising concerns about a rare condition ...

Abbvie said on Friday it will record a charge of about $3.5 billion related to its experimental schizophrenia drug, ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...

Taiwan Semiconductor Manufacturing (NYSE: TSM) stock rose 1.2% after the world’s biggest contract chipmaker reported ...

The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study ...

Using LEDs has the potential to bring down the cost of biomanufacturing, allowing such processes to make materials that ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

Austin Police Department detectives are investigating the second homicide of 2025 after a body was found at an apartment ...

Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.